Related Experiment Video

Updated: Jun 17, 2026

Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty
05:53

Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty

Published on: July 24, 2013

16.5K

Low CD4+ cell counts linked to mortality after sustained virological response: evaluating interaction with liver

Anaïs Corma-Gómez1,2,3,4, Jésica Martín-Carmona1,2,3,4, Juan A Pineda1,4

  • 1Clinical Virology and STIs Group, Unit of Infectious Diseases and Microbiology, Hospital Universitario de Valme, Seville, Spain.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|January 15, 2025
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies
07:10

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies

Published on: January 7, 2019

15.6K
Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models
09:54

Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models

Published on: December 3, 2019

8.9K

Related Experiment Videos

Last Updated: Jun 17, 2026

Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty
05:53

Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty

Published on: July 24, 2013

16.5K
Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies
07:10

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies

Published on: January 7, 2019

15.6K
Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models
09:54

Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models

Published on: December 3, 2019

8.9K

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...

Articles linked to this work by shared authors, journal, and citation graph.

Three-Year CD4/CD8 Ratio Recovery After Initiation of Dual Versus Triple Integrase Inhibitor-Based Therapy in Naïve Adults With HIV.

Open forum infectious diseases·2026

Landscape of copy number variants in Spanish people with dementia.

NPJ genomic medicine·2026

Unmet HIV and STI Prevention Needs and Limited Linkage to Care Among Gay, Bisexual, and Other Men Who Have Sex with Men in Southern Spain: A Community-Based Intervention Study.

AIDS patient care and STDs·2026

Trends in Age-Related Health Outcomes in People with HIV in Spain, 2006-2023.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2025

Long-term liver stiffness dynamics after sustained virological response in patients with HIV/HCV co-infection and advanced fibrosis.

AIDS (London, England)·2025

FibroScan-AST Score vs Liver Stiffness for the Prediction of Liver Events After HCV Cure.

Open forum infectious diseases·2025

The Impact of Isoniazid Preventive Therapy on Tuberculosis Infection and Disease Progression.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026

Evolution of Untreated Anal High-grade Squamous Intraepithelial Lesions in High-risk Men: A Prospective 5-year Clinical Follow-up in the ANRS-EP57-APACHES study.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026

Influenza Vaccination and Symptom Burden in Ambulatory Patients with Confirmed Influenza: Evidence from Case-ascertained Household Transmission Studies.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026

Quantitative PCR Bacterial Levels Cannot Distinguish Recurrent UTI from Other Non-infectious Urinary Symptoms.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026

Whole genome sequencing of influenza virus transmission pairs confirms the efficacy of baloxavir in reducing household transmission.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026

Real-World Experience of Hepatitis C Treatment With Glecaprevir-Pibrentasvir During Pregnancy.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026

Rotavirus-NSP5 interacts with and hijacks host ATP citrate lyase to viroplasms, enhancing lipid biosynthesis for facilitating rotavirus infection.

Virulence·2026

Banff Liver Allograft Pathology Group: late rejection activity is insufficiently represented in the current diagnostic framework - rationale and goals for revision.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2026

Detection and structural characterization of bat-associated dengue virus serotype 2: A country-level first detection in Pakistan.

Gene·2026

Selective decay of interferon mRNAs controls antiviral immunity and innate memory.

Molecular cell·2026

Low bacterial contamination rate in platelet components following primary culture screening: a Saudi Arabian experience.

Frontiers in medicine·2026

Nanoplastic Pollution of Human Bronchoalveolar Lavage Probed Based on Tip-Enhanced Raman Scattering.

Sensors (Basel, Switzerland)·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us